Panel Discussion at 3rd Interpet Osaka

I participated in the 3rd Interpet Osaka as one of the panelists for the panel discussion titled “Future outlook for the Japanese pet industry” on June 13th, 2025.
Thank you to the many friends and acquaintances who came to support me.
I was harsh on both original and generic manufacturers of animal medicines, but I would appreciate it if they could provide unbiased and accurate information, otherwise wholesalers and veterinarians will spread misinformation to pet owners.
Facilitator Chairman Dr. Koshimura also said, “Currently, senior dogs and cats account for more than half of the total, and newborn puppies and kittens account for less than 4%, so a significant decrease in the number of pets kept is inevitable. In 7-8 years, veterinary clinics will begin to be eliminated. Can anyone give their opinion on this?” He asked all the panelists and I answered since I was a representative of veterinarians there.
My biggest concern is that owners will stop visiting veterinary clinics due to rising veterinary medical costs, which is actually happening in the United States and other countries.

Japan in the World – Japan’s Animal Drug Market

At the request of the Japan Animal Drug Instrument Distributor Association, I ran 9 series of the above-titled document for two years.

I hope you will read the whole series from the following URL below by using ChatGPT as they are written in Japanese.

https://jadida.or.jp/supply_repo.html

  1. The world’s animal drug market is 6 trillion yen
  2. MAFF is seriously cultivating the next generation of food industry
  3. Learn about the dynamism of the animal drug industry through corporate exhibits at WVC
  4. How will the world confront diseases for which no approved animal drugs have yet been approved?
  5. Is the fear of avian flu spreading from cows to humans in Japan unfounded?
  6. International cooperation on drug regulations and prohibited acts in horse racing
  7. Japanese animal drug companies should be more proactive in disseminating information overseas
  8. There are Japanese companies that specialize in research and development and are making a splash in the global market
  9. Unless Japan’s market value improves, we cannot expect the development of the animal drug industry or a stable supply

Issue of shortages of veterinary medicines was discussed at 29th AVC GA

I had the opportunity to speak at the 29th AVC General Assembly held in Utrecht, the Netherlands, about the issue of shortages of veterinary medicines, which has emerged as a post-COVID issue.
It was a very meaningful opportunity to discuss the issue not only with consultants from each country, but also with Dr. Schalansky of the EU (European Community) EMA (European Medicines Agency).

Japan: Efforts for Stable Supply of Veterinary Medicines by Dr. Yuki Ujimasa, DVM, MS
VMP Shortages by Dr. Jana Schalansly, Head of Veterinary Strategic Support, EMA, EU

Stepping into the Japanese Animal Health Market

Would you like to grow your companion animal business outside the US but are not sure where and now?  How about in one of the most valuable markets in the world, Japan?  Brakke Consulting can help.

For the first time, Brakke Consulting will be presenting a seminar on taking the first step in Japan at the Western Veterinary Conference on Monday, February 19th from 9:30-10:30 am in the Acacia 1 room at the Four Seasons Hotel.  This seminar will be presented by Yuki Ujimasa, DVM, MS, a Brakke senior consultant based in Tokyo, who has broad experience in the Japanese market.  Yuki will focus on the steps needed to get your product approved by the regulatory authorities in Japan.  This will be a great seminar for companies looking to expand their global business but need some help to get started. 

Monday, February 19, 2024 at WVC
Four Seasons Hotel, Acacia Room